Gemfibrozil Tablets

Product/Composition Gemfibrozil Tablets
Strength 150mg. 300mg, 600mg
Form Tablet
Production Capacity 10 Million Tablets/Month
Packaging 10 X 10 Tablets / Box
Therapeutic use Cardiovascular
Package Insert/Leaflet Available upon request

Gemfibrozil Tablets are a medicine used to manage abnormal blood lipid levels, especially high triglycerides. They belong to a class of drugs called fibrates.

Here are the key details:

  • Composition: Each tablet contains Gemfibrozil, commonly in 600 mg strength.

  • Dosage Form: Oral tablets, usually taken twice daily, 30 minutes before meals, as prescribed by a doctor.

  • Mode of Action:

    • Gemfibrozil activates peroxisome proliferator-activated receptor alpha (PPARα) in the liver.

    • This increases the breakdown of triglycerides, lowers very low-density lipoprotein (VLDL), and can modestly raise high-density lipoprotein (HDL) cholesterol.

  • Uses:

    • Hypertriglyceridemia – very high triglyceride levels to reduce risk of pancreatitis.

    • Mixed dyslipidemia – high cholesterol with high triglycerides.

    • Often used when diet and lifestyle changes alone are insufficient to control lipid levels.

  • Treatment Goal: To lower triglycerides, improve cholesterol balance, and reduce cardiovascular risk.

  • Side Effects:

    • Common: stomach discomfort, nausea, diarrhea, headache, dizziness.

    • Less common/serious: liver function changes, gallstones, muscle pain or weakness (myopathy), allergic reactions.

  • Precautions:

    • Regular monitoring of liver function, kidney function, and blood lipid levels is recommended.

    • Use caution in patients with liver, kidney, or gallbladder disease.

    • Avoid combining with certain statins without doctor supervision due to increased risk of muscle damage.

    • Maintain a healthy diet and lifestyle alongside medication for optimal results.

👉 Gemfibrozil is effective for controlling high triglycerides and improving lipid profiles, especially in patients at risk for pancreatitis or cardiovascular disease.